» Articles » PMID: 35499038

Maternal Paracetamol Intake During Pregnancy-Impacts on Offspring Reproductive Development

Overview
Journal Front Toxicol
Date 2022 May 2
PMID 35499038
Authors
Affiliations
Soon will be listed here.
Abstract

Paracetamol (acetaminophen) is the preferred antipyretic/analgesic for pregnant women as it is believed there are no adverse fetal effects at the recommended dose. However, emerging evidence suggests that intrauterine paracetamol exposure may be associated with certain urogenital/reproductive disorders in the offspring. In this mini-review, we describe human fetal sex development and possible pharmacological mechanisms by which paracetamol may disrupt this process, including reduced testicular production of testosterone and/or insulin-like peptide 3. We then review the available epidemiological literature on associations between maternal paracetamol exposure and offspring sexual development. Three epidemiological studies have reported associations between maternal paracetamol intake and increased risk of cryptorchidism, although five others have not. None have found associations with hypospadias or penile length. Two out of three studies have reported a shorter anogenital distance (a marker of androgen action during the masculinisation programming window, ∼8-14 weeks of gestation) in male infants antenatally exposed to paracetamol. One study has described a dose-dependent relationship between maternal paracetamol consumption and earlier female (but not male) attainment of puberty. Such epidemiological analyses are complicated by various factors, including method of paracetamol exposure assessment (usually retrospective self-report), variation in diagnostic accuracy, selection bias, confounding by clinical indication, and demographic/genetic differences between geographically separated populations. There is an urgent need for stronger evidence in this area, from both relevant experimental studies and large, carefully-designed prospective studies. In the meantime, a precautionary attitude to gestational paracetamol usage should be considered as the evidence for clinically significant reproductive effects in humans is limited.

Citing Articles

Endocrine disruption and male reproductive disorders: unanswered questions.

Sharpe R Hum Reprod. 2024; 39(9):1879-1888.

PMID: 38926156 PMC: 11373384. DOI: 10.1093/humrep/deae143.


Decoction derived from L. bulbs and Sojae Semen Praeparatum alleviates wind-cold-type common cold Nrf2/HO-1 pathway and modulation of level.

Jiang Y, Wei W, Zhou J, Qiu S, Yang Q, Huo J Front Pharmacol. 2024; 15:1364328.

PMID: 38803435 PMC: 11129017. DOI: 10.3389/fphar.2024.1364328.


Effects of Acetaminophen on Reproductive Activities in Male Golden Hamsters.

Lee C, Hwang H, Park J, Lee S, Park C, Cheon Y Dev Reprod. 2023; 27(1):25-37.

PMID: 38075438 PMC: 10703095. DOI: 10.12717/DR.2023.27.1.25.

References
1.
Abreu A, Kaiser U . Pubertal development and regulation. Lancet Diabetes Endocrinol. 2016; 4(3):254-264. PMC: 5192018. DOI: 10.1016/S2213-8587(15)00418-0. View

2.
Interrante J, Ailes E, Lind J, Anderka M, Feldkamp M, Werler M . Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011. Ann Epidemiol. 2017; 27(10):645-653.e2. PMC: 5719491. DOI: 10.1016/j.annepidem.2017.09.003. View

3.
Modick H, Weiss T, Dierkes G, Bruning T, Koch H . Ubiquitous presence of paracetamol in human urine: sources and implications. Reproduction. 2014; 147(4):R105-17. DOI: 10.1530/REP-13-0527. View

4.
Bauer A, Swan S, Kriebel D, Liew Z, Taylor H, Bornehag C . Paracetamol use during pregnancy - a call for precautionary action. Nat Rev Endocrinol. 2021; 17(12):757-766. PMC: 8580820. DOI: 10.1038/s41574-021-00553-7. View

5.
Thankamony A, Ong K, Dunger D, Acerini C, Hughes I . Anogenital distance from birth to 2 years: a population study. Environ Health Perspect. 2010; 117(11):1786-90. PMC: 2801188. DOI: 10.1289/ehp.0900881. View